Omega Diagnostics Group Plc operates in the Electromedical equipment sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Omega Diagnostics Group Plc with three other
companies in this sector in the United Kingdom:
LiDCO Group PLC
sales of £7.59 million [US$9.85 million]
of which 100%
was Cardiac Monitoring),
Scientific Digital Imaging Plc
(£8.47 million [US$10.99 million]
of which 100%
was Digital Imaging), and
Cambridge Cognition Holdings Plc
(£6.88 million [US$8.92 million]
of which 70%
was Pharmaceutical Clinical Trials).
Omega Diagnostics Group Plc reported sales of £12.74 million (US$16.53 million)
March of 2016.
increase of 5.3%
versus 2015, when the company's sales were £12.11 million.
Sales at Omega Diagnostics Group Plc have increased during each of the previous five years
(and since 2011, sales have increased a total of 61%).
Sales of Food Intolerance saw an increase
that was more than double the company's growth rate: sales were up
18.7% in 2016, from
£5.95 million to £7.06 million.
Not all segments of Omega Diagnostics Group Plc experienced an increase in sales in 2016:
sales of Allergy and Autoimmune fell 12.6% to £3.16 million.
Omega Diagnostics Group Plc also experienced decreases in sales in
Infectious and Other (down 0.8% to £2.53 million)